SEARCH

SEARCH BY CITATION

References

  • Alaniz R. C., Thomas S. A., Perez M., Mueller K., Farr A. G., Palmiter R. D. and Wilson C. B. (1999) Dopamine beta-hydroxylase deficiency impairs cellular immunity. Proc. Natl Acad. Sci. USA 96, 22742278.
  • Bas G., Calopa M., Mestre M., Mollevi David Cutillas B., Ambrosio S. and Buendia E. (2001) Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism. J. Neuroimmunol. 113, 146152.
  • Basu S. and Dasgupta P. S. (2000) Dopamine, a neurotransmitter, influences the immune system. J. Neuroimmunol. 102, 113124.
  • Basu S., Dasgupta P. S., Lahiri T. and Chowdhury J. R. (1993) Uptake and biodistribution of dopamine in bone marrow, spleen and lymph nodes of normal and tumor bearing mice. Life Sci. 53, 415424.
  • Bellinger D. L., Felten S. Y., Lorton D. and Felten D. L. (1989) Origin of noradrenergic innervation of the spleen in rats. Brain Behav. Immun. 3, 291311.
  • Bellinger D. L., Lorton D., Felten S. Y. and Felten D. L. (1992) Innervation of lymphoid organs and implications in development, aging, and autoimmunity. Int. J. Immunopharmacol. 14, 329344.
  • Benschop R. J., Rodriguez F. and Schedlowski M. (1996) Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav. Immun. 10, 7791.
  • Benschop R. J., Schedlowski M., Wienecke H., Jacobs R. and Schmidt R. E. (1997) Adrenergic control of natural killer cell circulation and adhesion. Brain Behav. Immun. 11, 321332.
  • Bergquist J., Tarkowski A., Ekman R. and Ewing A. (1994) Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc. Natl Acad. Sci. USA 91, 1291212916.
  • Besedovsky H., Del Rey A., Da Sorkin E. P., Burri R. and Honegger C. (1983) The immune response evokes changes in brain noradrenergic neurons. Science 221, 564566.
  • Bieganowska K., Czéonkowska A., Bidziäski A., Mierzewska H. and Korlak J. (1993) Immunological changes in the MPTP-induced Parkinson's disease mouse model. J. Neuroimmunol. 42, 3337.
  • Cano G., Sved A. F., Rinaman L., Rabin B. S. and Card J. P. (2001) Characterization of the central nervous system innervation of the rat spleen using viral transneuronal tracing. J. Comp. Neurol. 439, 118.
  • Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156159.
  • Cross R. J. and Roszman T. L. (1988) Central catecholamine depletion impairs in vivo immunity but not in vitro lymphocyte activation. J. Neuroimmunol. 19, 3345.
  • Cross R. J., Jackson J. C., Brooks W. H., Sparks D. L., Markesbery W. R. and Roszman T. L. (1986) Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. Immunology 57, 145152.
  • Dantzer R., Konsman J. P., Bluthe R. M. and Kelley K. W. (2000) Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton. Neurosci. 85, 6065.
  • Deleplanque B., Neveu P. J., Vitiello S. and Le Moal M. (1992) Early effects of unilateral lesions of substantia nigra on immune reactivity. Neurosci. Lett. 135, 205209.
  • Deleplanque B., Vitiello S., Le Moal M. and Neveu P. J. (1994) Modulation of immune reactivity by unilateral striatal and mesolimbic dopaminergic lesions. Neurosci. Lett. 166, 216220.
  • Deng J., Ding H., Wu Z. Y., Wang Q., Shen X. Y. and Yang K. (1993) Effect of intracerebroventricular injection of 6-hydroxydopamine on the peripheral catecholamine and angiotensin II in SHR. J. Tongji Med. Univ. 13, 202205.
  • Devoino L., Alperina E., Galkina O. and Ilyutchenok R. (1997) Involvement of brain dopaminergic structures in neuroimmunomodulation. Int. J. Neurosci. 91, 213228.
  • Elenkov I. J., Wilder R. L., Chrousos G. P. and Vizi E. S. (2000) The sympathetic nerve – an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52, 595638.
  • Exton M. S. von H., Schult M., Voge J., Strubel T., Donath S., Steinmuller C., Seeliger H., Nagel E., Westermann J. and Schedlowski M. (1998) Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation. J. Neuroimmunol. 88, 182191.
  • Exton M. S., Schult M., Donath S., Strubel T., Del Bode U. R., Westermann J. and Schedlowski M. (1999) Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. Am. J. Physiol. 276, R1710R1717.
  • Exton M. S., Meier B. A., Gierce C., Mosen M. and Schedlowski M. (2002) Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and β-adrenoceptors. J. Neuroimmunol. 131, 2130.
  • Felten D. L. (1993) Direct innervation of lymphoid organs: substrate for neurotransmitter signaling of cells of the immune system. Neuropsychobiology 28, 110112.
  • Filipov N. M., Cao L., Seegal R. F. and Lawrence D. A. (2002) Compromised peripheral immunity of mice injected intrastriatally with six-hydroxydopamine. J. Neuroimmunol. 132, 129139.
  • Fiszer U., Piotrowska K., Korlak J. and Czéonkowska A. (1991) The immunological status in Parkinson's disease. Med. Lab. Sci. 48, 196200.
  • Fiszer U., Mix E., Fredrikson S., Kostulas V. and Link H. (1994) Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood. Acta Neurol. Scand. 90, 160166.
  • Jetschmann J. U., Benschop R. J., Jacobs R., Kemper A., Oberbeck R., Schmidt R. E. and Schedlowski M. (1997) Expression and in-vivo modulation of alpha- and beta-adrenoceptors on human natural killer (CD16+) cells. J. Neuroimmunol. 74, 159164.
  • Kluter H., Vieregge P., Stolze H. and Kirchner H. (1995) Defective production of interleukin-2 in patients with idiopathic Parkinson's disease. J. Neurol. Sci. 133, 134139.
  • Kohm A. P. and Sanders V. M. (2000) Norepinephrine: a messenger from the brain to the immune system. Immunol. Today 21, 539542.
  • Le Fur G., Meininger V., Phan T., Gerard A., Baulac M. and Uzan A. (1980a) Decrease in lymphocyte [3H]spiroperidol binding sites in Parkinsonism. Life Sci. 27, 15871591.
  • Le Fur G., Phan T. and Uzan A. (1980b) Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes. Life Sci. 26, 11391148.
  • Leblhuber F., Walli J., Jellinger K., Tilz G. P., Widner B., Laccone F. and Fuchs D. (1998) Activated immune system in patients with Huntington's disease. Clin. Chem. Lab. Med. 36, 747750.
  • Leonardi A., Caria M., Di Arata L. G., Canonica G. W. and Fudenberg H. H. (1986) Evidence of T-lymphocyte functional impairment in Huntington's disease. Clin. Immunol. Immunopathol. 39, 121130.
  • Madden K. (2001) Catecholamines, sympathetic nerves, and immunity, in Psychoneuroimmunology (AderR., FeltenD. L. and CohenN., eds), pp. 197216. Academic Press, San Diego.
  • Marttila R. J., Eskola J., Paivarinta M. and Rinne U.K. (1984) Immune functions in Parkinson's disease. Adv. Neurol. 40, 315323.
  • Muller N., Riedel M., Ackenheil M. and Schwarz M. J. (1999) The role of immune function in schizophrenia: an overview. Eur. Arch. Psychiatry Clin. Neurosci. 249, 6268.
  • Neveu P. J., Deleplanque B., Vitiello S., Rouge-Pont F. and Le Moal M. (1992) Hemispheric asymmetry in the effects of substantia nigra lesioning on lymphocyte reactivity in mice. Int. J. Neurosci. 64, 267273.
  • Ni Z., Bouali B., Gao D., Benabid A. L. and Benazzouz A. (2000) Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat. Eur. J. Neurosci. 12, 43384344.
  • Ni Z. G., Bouali B., Gao D. M., Benabid A. L. and Benazzouz A. (2001) Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats. Brain Res. 899, 142147.
  • Offen D., Ziv I., Gorodin S., Barzilai A., Malik Z. and Melamed E. (1995) Dopamine-induced programmed cell death in mouse thymocytes. Biochim. Biophys. Acta 1268, 171177.
  • Okamoto S., Ibaraki K., Hayashi S. and Saito M. (1996) Ventromedial hypothalamus suppresses splenic lymphocyte activity through sympathetic innervation. Brain Res. 739, 308313.
  • Paxinos G. and Watson S. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
  • Qiu Y., Peng Y. and Wang J. (1996) Immunoregulatory role of neurotransmitters. Adv. Neuroimmunol. 6, 223231.
  • Renoux G., Biziere K., Renoux M., Steinberg R., Kan J. P. and Guillaumin J. M. (1989) Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice. Life Sci. 44, 771777.
  • Saha B., Mondal A. C., Majumder J., Basu S. and Dasgupta P. S. (2001) Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4 + and CD8 + T cells in vitro: a receptor-mediated mechanism. Neuroimmunomodulation 9, 2333.
  • Sanders V. M. and Straub R. H. (2002) Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav. Immun. 16, 290332.
  • Sanders V. M., Kasprowicz D. J. and Swanson M. A. (2001) Neurotransmitter receptors on lymphocytes and other lymphoid cells, in Psychoneuroimmunology (AderR., FeltenD. L. and CohenN., eds), pp. 161166. Academic Press, San Diego.
  • Schedlowski M., Hosch W., Oberbeck R., Benschop R. J., Jacobs R., Raab H. R. and Schmidt R. E. (1996) Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms. J. Immunol. 156, 9399.
  • Stevens F. and Bellinger D. L. (1997) Noradrenergic and peptidergic innervation of lymphoid organs. Chem. Immunol. 69, 99131.
  • Teunis M. A., Kavelaars A., Voest E., Bakker J. M., Ellenbroek B. A., Cools A. R. and Heijnen C. J. (2002) Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system. FASEB J. 16, 14651467.
  • Tracey K. (2002) The inflammatory reflex. Nature 420, 853859.
  • Tsao C. W., Lin Y. S. and Cheng J. T. (1997) Effect of dopamine on immune cell proliferation in mice. Life Sci. 61, 361371.
  • Weihe E., Nohr D., Michel S., Muller S., Zentel H. J., Fink T. and Krekel J. (1991) Molecular anatomy of the neuro-immune connection. Int. J. Neurosci. 59, 123.
  • Xie Y., Frede S., Harnish M. J., Exton M. S. and Schedlowski M. (2002) Beta-adrenoceptor-induced inhibition of rat splenocyte proliferation: cytokine gene transcription as the target of action. Immunobiology 206, 345353.
  • Zalcman S., Shanks N. and Anisman H. (1991) Time-dependent variations of central norepinephrine and dopamine following antigen administration. Brain Res. 557, 6976.